SIRT1 and Alzheimer disease: Finally, a first-in-class small molecule, apolipoprotein E4 (ApoE4)-targeted SIRT1 A03, showed SIRT1-enhancing effects in the hippocampus of 5XFAD-ApoE4 AD model mice improving their performance in cognitive tasks.